Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.

Bast RC Jr, De Fabritiis P, Lipton J, Gelber R, Maver C, Nadler L, Sallan S, Ritz J.

Cancer Res. 1985 Feb;45(2):499-503.

2.

Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement.

De Fabritiis P, Bregni M, Lipton J, Greenberger J, Nadler L, Rothstein L, Korbling M, Ritz J, Bast RC Jr.

Blood. 1985 May;65(5):1064-70.

3.

Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.

Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC Jr.

Cancer Res. 1986 Mar;46(3):1208-13.

4.

Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.

Kulkarni SS, Wang ZM, Spitzer G, Taha M, Hamada H, Tsuruo T, Dicke KA.

Blood. 1989 Nov 1;74(6):2244-51.

5.
7.

Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complement.

De Fabritiis P, Bregni M, Lipton J, Reynolds C, Nadler L, Ritz J, Bast RC Jr.

Leuk Res. 1986;10(1):35-42.

PMID:
2935682
8.

Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.

Kvalheim G, Fodstad O, Pihl A, Nustad K, Pharo A, Ugelstad J, Funderud S.

Cancer Res. 1987 Feb 1;47(3):846-51.

9.

Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.

Montgomery RB, Kurtzberg J, Rhinehardt-Clark A, Haleen A, Ramakrishnan S, Olsen GA, Peters WP, Smith CA, Haynes BF, Houston LL, et al.

Bone Marrow Transplant. 1990 Jun;5(6):395-402.

PMID:
2369680
10.

Effects of monoclonal antibody and complement treatment of human marrow on hematopoiesis in continuous bone marrow culture.

Greenberger JS, Rothstein L, DeFabritiis P, Bregni M, Bast R Jr, Ritz J, Nadler LM, Lipton JM, Sakakeeny MA.

Cancer Res. 1985 Feb;45(2):758-67.

11.

Elimination of malignant clonogenic breast cancer cells from human bone marrow.

Anderson IC, Shpall EJ, Leslie DS, Nustad K, Ugelstad J, Peters WP, Bast RC Jr.

Cancer Res. 1989 Aug 15;49(16):4659-64.

12.

Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.

Bast RC Jr, Ritz J, Lipton JM, Feeney M, Sallan SE, Nathan DG, Schlossman SF.

Cancer Res. 1983 Mar;43(3):1389-94.

13.

Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement.

Haleem A, Kurtzberg J, Olsen GA, Rhinehardt-Clark A, Leslie DS, Ray L, Smith CA, Peters WP, Haynes BF, Bast RC Jr.

Cancer Res. 1987 Sep 1;47(17):4608-12.

15.

Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.

Uckun FM, Ramakrishnan S, Houston LL.

J Immunol. 1985 Mar;134(3):2010-6.

PMID:
3855433
16.
17.
19.

Elimination of leukemia cells from human bone marrow using floating beads.

Hirn-Scavennec J, Brailly H, Maraninchi D, Mannoni P, Mawas C, Delaage M.

Transplantation. 1988 Oct;46(4):558-63.

PMID:
3051563
20.

Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.

Slaper-Cortenbach IC, Admiraal LG, van Leeuwen EF, Kerr JM, von dem Borne AE, Tetteroo PA.

Exp Hematol. 1990 Jan;18(1):49-54.

PMID:
2298269

Supplemental Content

Support Center